Pacific Biosciences Of California reported $17.98M in Stock for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Accelerate Diagnostics AXDX:US 9.57M 213K
Agilent A:US $ 818M 27M
Bruker BRKR:US $ 730.2M 29.5M
Danaher DHR:US $ 2547M 123M
Fluidigm FLDM:US $ 25.07M 3.18M
General Electric GE:US $ 17016M 486M
Genmark Diagnostics GNMK:US $ 21.32M 1.75M
Illumina ILMN:US $ 380M 16M
Luminex LMNX:US $ 132.09M 8.96M
Myriad Genetics MYGN:US $ 17.7M 6.9M
Nanostring Technologies NSTG:US $ 28.7M 4.26M
Oxford Immunotec Global OXFD:US $ 13.1M 0.28M
Pacific Biosciences Of California PACB:US $ 17.98M 1.72M
Perkinelmer PKI:US $ 513.43M 16.48M
Quidel QDEL:US $ 218.51M 43.84M
Thermo Fisher Scientific TMO:US $ 4625M 283M